Figure 5
From: The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function
Functional impairment of DCs matured in the presence of LEF-M. Immature dendritic cells (iDCs) were exposed to lipopolysaccharide (LPS; 100 ng/ml) in the absence or presence of the indicated concentrations of the active metabolite of leflunomide (LEF-M). Then, the cells were extensively washed, irradiated (3000 rad) and subsequently co-cultured with 1 × 105 purified allogeneic T cells at the indicated ratios. DNA synthesis was assessed after 5 days and was measured in triplicate. The standard deviation of triplicates was generally below 20%. The data shown are expressed as mean counts/min (cpm) of four independent experiments.